cbdMDYCBD -1.12%38 Days Payable is 43.54 as of Mar. 2026, which is 39% below its 10-year median of 71.73. GuruFocus rates YCBD with a GF Score™ of 38/100 and a GF Value™ of $0.16 (Significantly Overvalued). The stock has 2 warning signs investors should review. Among 923 Drug Manufacturers companies, cbdMD ranks worse than 72.81% on this metric.
cbdMD's average Accounts Payable for the
three
months ended in Mar. 2026 was $1.14 Mil. cbdMD's Cost of Goods Sold for the
three
months ended in Mar. 2026 was $2.38 Mil.
Hence, cbdMD's Days Payable for the
three
months ended in Mar. 2026 was 43.54.
The historical rank and industry rank for cbdMD's Days Payable or its related term are showing as below:
YCBD'
s Days Payable Range Over the Past 10 Years
Min: 32.35 Med: 71.73 Max: 1661.8
Current: 53.53
During the past 11 years, cbdMD's highest Days Payable was 1661.80. The lowest was 32.35. And the median was 71.73.
YCBD's Days Payable is ranked worse than 72.81% of 923
companies
in the Drug Manufacturers industry
Industry Median: 90.98
vs YCBD: 53.53
cbdMD's Days Payable
declined
from Mar. 2025 (62.42) to Mar. 2026 (43.54).
It may suggest that cbdMDaccelerated paying its suppliers.
cbdMD Days Payable Related Terms
cbdMD Days Payable Historical Data
* Premium members only.
The historical data trend for cbdMD's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, cbdMD's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
cbdMD Days Payable vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, cbdMD's Days Payable distribution charts can be found below:
* The bar in red indicates where cbdMD's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
cbdMD's Days Payable for the fiscal year that ended in Sep. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
cbdMD (YCBD) has a Days Payable of 43.54 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on cbdMD and its competitors. This is 39% below median its historical median of 71.73. Over the past decade, cbdMD's Days Payable has ranged from 32.35 to 1,661.80. According to the industry distribution chart, cbdMD ranks #672 out of 923 companies in the Drug Manufacturers industry, placing it in the top 72.8%.
Is cbdMD's Days Payable too high?
cbdMD's current Days Payable of 43.54 is 39% below median its 10-year median of 71.73. Over the past 10 years, this metric has ranged from a low of 32.35 to a high of 1,661.80. The Drug Manufacturers industry median Days Payable is 90.98. cbdMD's value of 43.54 is 52.1% below this industry median. Based on the distribution chart, cbdMD ranks #672 out of 923 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, cbdMD has a GF Score™ of 38/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does cbdMD's Days Payable compare to SXTC and CABR?
According to the Drug Manufacturers industry distribution chart, cbdMD ranks #672 out of 923 companies for Days Payable. This places cbdMD in the lower half of its industry. The industry median Days Payable is 90.98. cbdMD's value of 43.54 is 52.1% below this benchmark. Historically, cbdMD's own Days Payable has ranged from 32.35 to 1,661.80 over the past decade. While the company's 10-year median is 71.73 vs. the industry median of 90.98, cbdMD has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Drug Manufacturers company?
The median Days Payable among Drug Manufacturers companies is 90.98, based on 923 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. cbdMD's current Days Payable of 43.54 is 52.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on cbdMD and its competitors. For the Drug Manufacturers industry, the median Days Payable is 90.98 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. cbdMD's current Days Payable is 43.54, which is 39% below median its own 10-year median of 71.73. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is cbdMD stock overvalued right now?
Based on GuruFocus' analysis, cbdMD (YCBD) is currently considered Significantly Overvalued. The stock's GF Value™ is $0.16, compared to a current price of $0.70 — trading 334.4% above its estimated fair value. The current Days Payable is 43.54, which is 39% below median its 10-year median of 71.73 and 52.1% below the Drug Manufacturers industry median of 90.98. cbdMD's overall GF Score™ is 38/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For cbdMD (YCBD), the current Days Payable is 43.54 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is cbdMD (YCBD) Overvalued in 2026?
Based on GuruFocus' analysis, cbdMD stock appears to be overvalued.
The current stock price of $0.70 is trading 334.4% above its estimated GF Value™ of $0.16.
GuruFocus considers cbdMD to be Significantly Overvalued.
Key valuation signals for YCBD:
Days Payable: 43.54 (39% below median its 10-year median of 71.73)
GF Value™: $0.16 vs. price of $0.70 (334.4% above fair value)
Industry Position: 52.1% below the Drug Manufacturers median (#672 of 923)
No single metric tells the full story. See the YCBD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
cbdMD Inc is a United States based company. It owns and operates the consumer hemp-based cannabidiol (CBD) brand, cbdMD, Paw CBD as well as ATRx Labs brand of functional mushrooms. The company's product categories include CBD tinctures, CBD gummies, CBD topicals, CBD capsules, CBD oils, and CBD pet products. The firm distributes its products through an e-commerce website, wholesalers, and a variety of brick-and-mortar retailers.
38GF Score
Get the complete analysis for YCBD
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
YCBD has been successfully added to your 
